Cargando…

Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease

BACKGROUND: Crohn’s disease (CD) has a tendency for recurrence and requires adequate monitoring and personalized treatment. Since endoscopy is considerably invasive, serum biomarkers are required as alternatives for CD monitoring. Toward this, exosomal microRNAs (miRNAs) may serve as promising candi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peng, Huang, Shanshan, Yu, Qiao, Chao, Kang, Wang, Ying, Zhou, Gaoshi, Zhuang, Xiaojun, Zeng, Zhirong, Chen, Minhu, Zhang, Shenghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973006/ https://www.ncbi.nlm.nih.gov/pubmed/35382172 http://dx.doi.org/10.1093/gastro/goab056

Ejemplares similares

Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022)

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
por: Huang, Shanshan, et al.
Publicado: (2023)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020)

Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
por: Zhou, Gaoshi, et al.
Publicado: (2022)

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease
por: Wang, Huiling, et al.
Publicado: (2016)

Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023)

Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019)

Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn's Disease: A Systematic Review
por: Zhuang, Xiaojun, et al.
Publicado: (2021)

Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqin, et al.
Publicado: (2020)

Correction to: Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqing, et al.
Publicado: (2020)

Promising Roles of Exosomal microRNAs in Systemic Lupus Erythematosus
por: Wang, Wenqian, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions
por: Chen, Rirong, et al.
Publicado: (2023)

Mucosa-Associated Oscillospira sp. Is Related to Intestinal Stricture and Post-Operative Disease Course in Crohn’s Disease
por: Zhan, Shukai, et al.
Publicado: (2023)

Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
por: Chen, Rirong, et al.
Publicado: (2023)

Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
por: Xie, Zhuo, et al.
Publicado: (2021)

Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers
por: Wohnhaas, Christian T, et al.
Publicado: (2020)

Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
por: Lin, Lihui, et al.
Publicado: (2020)

Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease
por: Chen, Rirong, et al.
Publicado: (2021)

Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease
por: Zhao, Yue, et al.
Publicado: (2020)

A New Model Based on 25-Hydroxyvitamin D3 for Predicting Active Crohn's Disease in Chinese Patients
por: Lin, Sinan, et al.
Publicado: (2018)

MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers
por: Zhou, Meng, et al.
Publicado: (2020)

Serum MicroRNAs Are Promising Novel Biomarkers
por: Gilad, Shlomit, et al.
Publicado: (2008)

MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?
por: de Araújo, Helena Varela, et al.
Publicado: (2022)

Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway
por: Wen, Zhuzhi, et al.
Publicado: (2020)

Exosomal MicroRNAs in Serum as Potential Biomarkers for Ectopic Pregnancy
por: Sun, Jianhua, et al.
Publicado: (2020)

MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2
por: Sun, Xin-bo, et al.
Publicado: (2021)

Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice
por: Lin, Lihui, et al.
Publicado: (2022)

Circulating microRNA-144-5p is associated with depressive disorders
por: Wang, Xiao, et al.
Publicado: (2015)

microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma
por: Zheng, Qian, et al.
Publicado: (2020)

A nomogram incorporating ileal and anastomotic lesions separately to predict the long-term outcome of Crohn’s disease after ileocolonic resection
por: Xiong, Shanshan, et al.
Publicado: (2023)

MicroRNA-144 inhibits migration and proliferation in rectal cancer by downregulating ROCK-1
por: CAI, SHANG-DANG, et al.
Publicado: (2015)

MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression
por: Liu, Jun, et al.
Publicado: (2015)

Down-regulation of microRNA-144 in air pollution-related lung cancer
por: Pan, Hong-Li, et al.
Publicado: (2015)

The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
por: Gallo, Alessia, et al.
Publicado: (2012)

Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
por: Sohn, Won, et al.
Publicado: (2015)

Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis
por: Zhang, Lu, et al.
Publicado: (2020)

Clinical impact of serum exosomal microRNA in liver fibrosis
por: Chang, Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16reasib4oh6nprkquah0kluar